By expenditures
| Name | Title | Type |
|---|---|---|
| Holly Langan | Executive Director Of Financial Services | Auditee |
| Roy Rogers | Partner | Auditee |
| Roy R Rogers | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 391885 | 2025 | 2026-03-13 | SENSIBA LLP | $19.86M |
| 358761 | 2024 | 2025-06-12 | Pauly Rogers and CO | $31.28M |
| 301042 | 2023 | 2024-03-29 | Pauly Rogers and CO PC | $31.25M |
| 40856 | 2022 | 2023-07-04 | Pauly Rogers and CO PC | $24.40M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 391885 | 2025 | 2026-03-13 | 1179478 | 2025-001 | Material Weakness | Yes | I |
| 391885 | 2025 | 2026-03-13 | 1179477 | 2025-001 | Material Weakness | Yes | I |
| 391885 | 2025 | 2026-03-13 | 1179476 | 2025-001 | Material Weakness | Yes | I |
| 391885 | 2025 | 2026-03-13 | 1179475 | 2025-001 | Material Weakness | Yes | I |
| 391885 | 2025 | 2026-03-13 | 1179474 | 2025-001 | Material Weakness | Yes | I |
| 391885 | 2025 | 2026-03-13 | 1179473 | 2025-001 | Material Weakness | Yes | I |
| 391885 | 2025 | 2026-03-13 | 1179472 | 2025-001 | Material Weakness | Yes | I |
| 391885 | 2025 | 2026-03-13 | 1179471 | 2025-001 | Material Weakness | Yes | I |
| 391885 | 2025 | 2026-03-13 | 1179470 | 2025-001 | Material Weakness | Yes | I |
| 391885 | 2025 | 2026-03-13 | 1179469 | 2025-001 | Material Weakness | Yes | I |
| 391885 | 2025 | 2026-03-13 | 1179468 | 2025-001 | Material Weakness | Yes | I |
| 391885 | 2025 | 2026-03-13 | 1179467 | 2025-001 | Material Weakness | Yes | I |
| 391885 | 2025 | 2026-03-13 | 1179466 | 2025-001 | Material Weakness | Yes | I |
| 391885 | 2025 | 2026-03-13 | 1179465 | 2025-001 | Material Weakness | Yes | I |
| 391885 | 2025 | 2026-03-13 | 1179464 | 2025-001 | Material Weakness | Yes | I |
| 391885 | 2025 | 2026-03-13 | 1179463 | 2025-001 | Material Weakness | Yes | I |
| 391885 | 2025 | 2026-03-13 | 1179462 | 2025-001 | Material Weakness | Yes | I |
| 391885 | 2025 | 2026-03-13 | 1179461 | 2025-001 | Material Weakness | Yes | I |
| 391885 | 2025 | 2026-03-13 | 1179460 | 2025-001 | Material Weakness | Yes | I |
| 391885 | 2025 | 2026-03-13 | 1179459 | 2025-001 | Material Weakness | Yes | I |
| 391885 | 2025 | 2026-03-13 | 1179458 | 2025-001 | Material Weakness | Yes | I |
| 391885 | 2025 | 2026-03-13 | 1179457 | 2025-001 | Material Weakness | Yes | I |
| 391885 | 2025 | 2026-03-13 | 1179456 | 2025-001 | Material Weakness | Yes | I |
| 391885 | 2025 | 2026-03-13 | 1179455 | 2025-001 | Material Weakness | Yes | I |
| 391885 | 2025 | 2026-03-13 | 1179454 | 2025-001 | Material Weakness | Yes | I |
| 391885 | 2025 | 2026-03-13 | 1179453 | 2025-004 | Material Weakness | Yes | G |
| 391885 | 2025 | 2026-03-13 | 1179452 | 2025-004 | Material Weakness | Yes | G |
| 391885 | 2025 | 2026-03-13 | 1179451 | 2025-004 | Material Weakness | Yes | G |
| 301042 | 2023 | 2024-03-29 | 966584 | 2023-001 | Significant Deficiency | - | N |
| 301042 | 2023 | 2024-03-29 | 966583 | 2023-001 | Significant Deficiency | - | N |
| 301042 | 2023 | 2024-03-29 | 966582 | 2023-001 | Significant Deficiency | - | N |
| 301042 | 2023 | 2024-03-29 | 966581 | 2023-001 | Significant Deficiency | - | N |
| 301042 | 2023 | 2024-03-29 | 390142 | 2023-001 | Significant Deficiency | - | N |
| 301042 | 2023 | 2024-03-29 | 390141 | 2023-001 | Significant Deficiency | - | N |
| 301042 | 2023 | 2024-03-29 | 390140 | 2023-001 | Significant Deficiency | - | N |
| 301042 | 2023 | 2024-03-29 | 390139 | 2023-001 | Significant Deficiency | - | N |
| 40856 | 2022 | 2023-07-04 | 622556 | 2022-001 | Significant Deficiency | - | L |
| 40856 | 2022 | 2023-07-04 | 622555 | 2022-001 | Significant Deficiency | - | L |
| 40856 | 2022 | 2023-07-04 | 622554 | 2022-001 | Significant Deficiency | - | L |
| 40856 | 2022 | 2023-07-04 | 622553 | 2022-001 | Significant Deficiency | - | L |
| 40856 | 2022 | 2023-07-04 | 622552 | 2022-001 | Significant Deficiency | - | L |
| 40856 | 2022 | 2023-07-04 | 622551 | 2022-001 | Significant Deficiency | - | L |
| 40856 | 2022 | 2023-07-04 | 46114 | 2022-001 | Significant Deficiency | - | L |
| 40856 | 2022 | 2023-07-04 | 46113 | 2022-001 | Significant Deficiency | - | L |
| 40856 | 2022 | 2023-07-04 | 46112 | 2022-001 | Significant Deficiency | - | L |
| 40856 | 2022 | 2023-07-04 | 46111 | 2022-001 | Significant Deficiency | - | L |
| 40856 | 2022 | 2023-07-04 | 46110 | 2022-001 | Significant Deficiency | - | L |
| 40856 | 2022 | 2023-07-04 | 46109 | 2022-001 | Significant Deficiency | - | L |